The FDA has issued a Class II drug recall (D-0369-2026) for Dynarex Obstetrical Towelettes Cleanser (Benzalkonium Chloride 0.13%) manufactured for Dynarex Corporation. The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified in the manufacturing process. The product was distributed nationwide across the United States.

Drug manufacturers and distributors must immediately identify and quarantine affected product lots. Compliance officers should review their CGMP adherence and distribution records to ensure no further affected product remains in circulation. While specific penalties are not detailed, failure to comply with recall procedures can result in significant regulatory action and reputational damage.